| Castration-resistant Prostate Cancer and Intra-prostatic Hormonal Status (NCT03014973) | Hopital Foch | 2017-01-01 |
| Early Prostate Cancer: Predicting Treatment Response (NCT03770351) | University of California, Irvine | 2017-01-01 |
| Accuracy of Lymph Node Imaging in Prostate Cancer: PSMA PET-CT and Nano-MRI (NCT03223064) | Radboud University Medical Center | 2016-12-30 |
| A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers (NCT02643303) | Ludwig Institute for Cancer Research | 2016-12-28 |
| Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy (NCT02946996) | Medical University of South Carolina | 2016-12-28 |
| Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery (NCT02812186) | Stony Brook University | 2016-12-27 |
| A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study (NCT02960022) | Astellas Pharma Global Development, Inc. | 2016-12-22 |
| Trial of Rad-223 Activity in Asymptomatic Patients With mCRPC While on Abiraterone or Enzalutamide Besides AR-V7 Status (NCT03002220) | MedSIR | 2016-12-21 |
| Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients (NCT06473259) | Santa Chiara Hospital | 2016-12-16 |
| Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate Cancer (NCT02788773) | Canadian Cancer Trials Group | 2016-12-15 |
| Hyperpolarized Carbon-13 Imaging of Metastatic Prostate Cancer (NCT02844647) | Sunnybrook Health Sciences Centre | 2016-12-15 |
| Hypofractionated Whole Pelvic Radiotherapy of the Prostate (NCT02546427) | Albert J. Chang | 2016-12-09 |
| Electrical Patient Reported Outcome of Prostate Cancer RadioTherapy (NCT05187026) | Helsinki University Central Hospital | 2016-12-09 |
| Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer (NCT04489745) | VA Greater Los Angeles Healthcare System | 2016-12-01 |
| Comparison of Pain Levels in Fusion Prostate Biopsy and Standard TRUS-Guided Biopsy (NCT03859804) | TC Erciyes University | 2016-12-01 |
| A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer Progression (NCT03103152) | Queen Mary University of London | 2016-12-01 |
| Phase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPC (NCT03042468) | Weill Medical College of Cornell University | 2016-12-01 |
| Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer (NCT02793219) | The University of Texas Health Science Center, Houston | 2016-12-01 |
| Anorectal Application of 5% Lidocaine Cream Reduces Pain Prior to Periprostatic Nerve Block During Transrectal Ultrasound Guided Biopsy (NCT04064047) | Assaf-Harofeh Medical Center | 2016-12-01 |
| Study of Olaparib (± Degarelix) Given to Men With Intermediate/High Risk Prostate Cancer Before Prostatectomy (NCT02324998) | Cambridge University Hospitals NHS Foundation Trust | 2016-12-01 |
| Docetaxel Followed by Provenge in Metastatic Prostate Cancer (NCT02793765) | The University of Texas Health Science Center, Houston | 2016-12-01 |
| Seoul National University Prospectively Enrolled Registry for Prostate Cancer With Active Surveillance (NCT02971085) | Seoul National University Hospital | 2016-12-01 |
| Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer Patients (NCT03120832) | Sensei Biotherapeutics, Inc. | 2016-12-01 |
| Urology of Virginia Case Series (NCT03035487) | Exact Imaging | 2016-12-01 |
| Platelet Rich Plasma During Radical Prostatectomy (NCT02957149) | Mayo Clinic | 2016-12-01 |
| Use of a Biodegradable Balloon for the Treatment of Prostate Cancer by Intensity Modulated Radiotherapy (BioPro-RCMI) (NCT02478112) | Centre Oscar Lambret | 2016-11-25 |
| Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors (NCT02717156) | University of Southern California | 2016-11-21 |
| Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials (NCT02948413) | National Institutes of Health Clinical Center (CC) | 2016-11-10 |
| Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (HP) (13C) in Castration-Resistant Prostate Cancer (NCT02911467) | Rahul Aggarwal | 2016-11-08 |
| Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer (NCT02918968) | Astellas Pharma Inc | 2016-11-02 |
| PRostate Evaluation for Clinically Important Disease: MRI vs Standard Evaluation Procedures (NCT02936258) | Canadian Urology Research Consortium | 2016-11-01 |
| Randomized AmnioFix Study During Radical Prostatectomy (NCT02645591) | M.D. Anderson Cancer Center | 2016-11-01 |
| 68Ga-NOTA-RM26 PET/CT in Prostate Cancer Patients (NCT03164837) | Peking Union Medical College Hospital | 2016-11-01 |
| Explaining the Invisible Using the PEARL System (NCT03025633) | Hull University Teaching Hospitals NHS Trust | 2016-11-01 |
| Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium (NCT02928692) | RenJi Hospital | 2016-11-01 |
| CTC Immune Checkpoint (NCT02456571) | Duke University | 2016-11-01 |
| Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases (NCT02759783) | Royal Marsden NHS Foundation Trust | 2016-11-01 |
| Choline PET/CT vs. MeAIB PET/CT in Prostate Cancer (NCT02232672) | Odense University Hospital | 2016-11-01 |
| PROstaTe Cancer - Exercise-STudy (PRO-TEST) (NCT02954783) | Rigshospitalet, Denmark | 2016-11-01 |
| Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer (NCT02981368) | Progenics Pharmaceuticals, Inc. | 2016-11-01 |
| Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer (NCT03889119) | Hoag Memorial Hospital Presbyterian | 2016-10-21 |
| Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor Malignancies (NCT02913131) | Rahul Aggarwal | 2016-10-20 |
| Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy (NCT02903368) | Dana-Farber Cancer Institute | 2016-10-19 |
| HDR Focal: Feasibility Study (NCT02918253) | University Health Network, Toronto | 2016-10-14 |
| Glycosylation of Exosomes in Prostate and Urothelial Carcinoma (NCT04960956) | Indiana University | 2016-10-13 |
| MRI With C13 Pilot Study Prostate Cancer (NCT02450201) | University of California, San Francisco | 2016-10-12 |
| Hypofractionated Radiotherapy for Prostate Cancer (NCT03851926) | Consorci Sanitari de Terrassa | 2016-10-05 |
| SPCG17: Prostate Cancer Active Surveillance Trigger Trial (NCT02914873) | Uppsala University | 2016-10-03 |
| 5 Fractions of Pelvic SABR With Intra Prostatic SABR (NCT02911636) | Andrew Loblaw | 2016-10-01 |
| Charité HT-Prostate (NCT04159051) | Charite University, Berlin, Germany | 2016-10-01 |
| RADTOX: Measuring Radiation Toxicity Using Circulating DNA (NCT02941029) | University of Florida | 2016-10-01 |
| Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE) (NCT02704832) | Institut Bergonié | 2016-09-30 |
| Pivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate Cancer (NCT02766543) | Profound Medical Inc. | 2016-09-21 |
| PACCT: Partnering Around Cancer Clinical Trials (NCT02906241) | Susan Eggly | 2016-09-20 |
| Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041 (NCT02826382) | Five Eleven Pharma, Inc. | 2016-09-20 |
| Living With Prostate Cancer (LPC) (NCT03177759) | Vancouver Prostate Centre | 2016-09-09 |
| Improving Evidence-Based Care for Cancer Patients (NCT03207594) | Medical University of South Carolina | 2016-09-01 |
| Preference-based Comparative Study on Definitive Radiotherapy of Prostate Cancer With Protons (NCT02766686) | Technische Universität Dresden | 2016-09-01 |
| A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancer (NCT02747342) | Atridia Pty Ltd. | 2016-09-01 |
| PET-CT/MRI in the Radiotherapy for Prostate Cancer (NCT02816840) | Xuzhou Medical University | 2016-09-01 |
| Assessment of Bone Loss in Men Receiving Treatment for Prostate Cancer (NCT02785627) | Prof Janet Brown | 2016-09-01 |
| Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial) (NCT02543255) | University Health Network, Toronto | 2016-09-01 |
| Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201 (NCT02887976) | GU Research Network, LLC | 2016-09-01 |
| Reducing Sedentary Behaviour With Technology (NCT02911649) | University Health Network, Toronto | 2016-09-01 |
| The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancer (NCT02840552) | Sir Mortimer B. Davis - Jewish General Hospital | 2016-09-01 |
| A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057 (NCT02916537) | Cancer Targeted Technology | 2016-09-01 |
| Prostatic Artery Embolization Before Radical Prostatectomy in Prostate Cancer: A Proof-of-concept Study (NCT02917161) | Dominik Abt | 2016-09-01 |
| Safety and Efficacy of Firmagon® (Degarelix) for Injection (NCT02886598) | Ferring Pharmaceuticals | 2016-09-01 |
| Utility of Dynamic Variables Measured by Calibrated Pulse Contour Analysis of Oesophageal Doppler Monitor for Predicting Fluid Responsiveness During Robot-Assisted Laparoscopic Prostatectomy (NCT02886546) | Hallym University Kangnam Sacred Heart Hospital | 2016-09-01 |
| Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer (NCT02911922) | Weill Medical College of Cornell University | 2016-09-01 |
| Evaluation of Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins. (NCT03254420) | Institut du Cancer de Montpellier - Val d'Aurelle | 2016-08-30 |
| Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination Thru Engagement in Mindfulness Education (NCT02871752) | Northwestern University | 2016-08-10 |
| Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate Cancer (NCT02856100) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-08-03 |
| ADT Exercise Trial and Economic Analysis (NCT02834416) | University Health Network, Toronto | 2016-08-01 |
| Study of Carbon Dioxide Exchange Patterns During Robotic Prostatectomies (NCT02114164) | OhioHealth | 2016-08-01 |
| 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases (NCT02721433) | Ottawa Hospital Research Institute | 2016-08-01 |
| Improving Bio-availability of the Expensive Oral Oncolytic Drug Abiraterone by Food Intake (NCT02883166) | Radboud University Medical Center | 2016-08-01 |
| Outcomes From a RCT Comparing Preventive Versus Delayed Ligation of DVC During Robot-assisted Radical Prostatectomy (NCT03351088) | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2016-08-01 |
| Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning (NCT02681614) | Case Comprehensive Cancer Center | 2016-07-21 |
| Improving Health Literacy in African-American Prostate Cancer Patients (NCT03322891) | Emory University | 2016-07-21 |
| CHAMP: A Randomized Controlled Trial of High-intensity Aerobic and Resistance Exercise for Metastatic Prostate Cancer (NCT02613273) | University of California, San Francisco | 2016-07-18 |
| Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes (NCT02917798) | Memorial Sloan Kettering Cancer Center | 2016-07-12 |
| Quell Opioid Reduction and Pain Relief in Patients With Cancer (NCT02809846) | Scripps Translational Science Institute | 2016-07-01 |
| Integration of Cancer Health Activities Into African American Churches (NCT03178383) | University of Maryland, College Park | 2016-07-01 |
| Improved Prostate Cancer Diagnosis - Combination of Rapid Prebiopsy Magnetic Resonance Imaging and Biomarkers (NCT02844829) | Turku University Hospital | 2016-07-01 |
| A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer (NCT02844699) | Panacela Labs LLC | 2016-07-01 |
| Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancer (NCT02478125) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-07-01 |
| Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer (NCT02833883) | Memorial Sloan Kettering Cancer Center | 2016-07-01 |
| Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy (NCT02252978) | Wake Forest University Health Sciences | 2016-07-01 |
| Ibrutinib as Neoadjuvant Therapy in Localized Prostate Cancer (NCT02643667) | Washington University School of Medicine | 2016-07-01 |
| FACBC Prostate Therapy Response (NCT02830880) | Emory University | 2016-07-01 |
| Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients (NCT02997709) | University of Miami | 2016-06-24 |
| Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer (NCT02339168) | University of California, Davis | 2016-06-22 |
| Optical Tomography in Prostate Cancer (NCT03215992) | Columbia University | 2016-06-13 |
| Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone (NCT02640534) | Swiss Cancer Institute | 2016-06-10 |
| A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance (NCT02799745) | Astellas Pharma Global Development, Inc. | 2016-06-09 |
| Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer (NCT02825875) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-06-08 |
| Serial mpMRI (Multi Parametric Magnetic Resonance Imaging) Scanning in Prostate Cancer After Androgen Deprivation Therapy and RadioTherapy (NCT02721784) | University College, London | 2016-06-01 |
| Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy (NCT02220829) | Sir Mortimer B. Davis - Jewish General Hospital | 2016-06-01 |
| Retrograde Perfusion Sphinterometry and Autologous Sling to Improve Urinary Continence in Robotic Radical Prostatectomy (NCT03050996) | Istituto Auxologico Italiano | 2016-06-01 |